| Astrazeneca (1) |  |
| Basi (30) | |
| Bayer (5) | |
| Glaxosmithkline (2) | |
| Sanofi (1) | |
| Astrazeneca (1) | |
| Basi (30) | |
| Bayer (5) | |
| Glaxosmithkline (2) | |
| Sanofi (1) | |
Glaxosmithkline Vice president for Africa told CNN. t is the first time anyone ever has been able to make a vaccine against a parasite.
Perhaps most impressive, Glaxosmithkline, the pharmaceutical company that worked on this vaccine for 30 years, and received $200 million from the Gates Foundation, is making RTS, S available as a nonprofit drug.
< Back - Next >
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011